As innovations arise from the artificial intelligence, robotics and biotechnology sectors, holders of family capital from around the world will convene in Hong Kong to discuss such investment opportunities at the city’s fourth annual Wealth for Good Summit on March 23 and 24. Secretary for Financial Services and the Treasury Christopher Hui Ching-yu said the…
Mainland China and Hong Kong should ease listing rules for biotechnology companies and lower takeover thresholds for listed firms to capitalise on renewed foreign interest in the healthcare sector, venture capitalist Nisa Leung said. “Besides artificial intelligence, Premier Li Qiang also highlighted biomedicine in the ‘two sessions’ annual government work report,” said Leung, a managing…
Hong Kong’s cash-for-residency scheme has attracted about HK$95 billion (US$12 billion) from more than 1,700 investors over the past two years, with around two-thirds of the approved capital channelled into authorised funds and equities, the latest figures from InvestHK show. The government’s investment promotion arm on Monday released the figures for the New Capital Investment…
Hong Kong IPOs 2025: Market views, mega deals, emerging trends Hong Kong cemented its status as the world’s leading initial public offerings venue in 2025, marking a year of momentum, progress and transformation. By mid-December, the market had raised HKD274.6 billion (USD35.2 billion) from 106 new listings, with four of the world’s top 10 IPOs…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. It’s an exciting week not only for biotech M&A, but also for my city (Chicago) as we gear up for our big game this Saturday. Going into JPM, it’s good to be a…
The recent opening of the Hong Kong-Shenzhen Innovation and Technology Park in the Hetao cooperation zone is a defining milestone in Hong Kong’s journey to become an international tech hub. Heralded by Chief Executive John Lee Ka-chiu as a pivotal moment for local innovation, this is more than just a new facility; it marks a…
Adlai Nortye (NASDAQ: ANL) entered an exclusive license agreement with ASK Pharm for its pan‑RAS (ON) inhibitor AN9025 in mainland China, Hong Kong and Macao on Dec 29, 2025. ASK Pharm gains rights to develop, manufacture, and commercialize AN9025 in the Licensed Territory while Adlai Nortye retains worldwide rights elsewhere. The deal…
Go back a decade and most Americans had never heard of Huawei. Today, the Chinese telecom giant is a symbol of how quickly China can dominate a strategic technology sector and in the process create new national security and market threats for U.S. government and industry. Democratic Senator Mark Warner of Virginia, the top Democrat…
Pentagon personnel could soon be told to participate in new training programs designed to prepare them for anticipated advancements in biotechnology and its convergence with other critical and emerging technologies, like quantum computing and AI. House lawmakers recently passed an amendment en bloc in their version of the fiscal 2026 National Defense Authorization Act that…
Last month, I joined a US think tank delegation to China, participating in a round table at a top university in Beijing. A remark by a leading professor of diplomacy struck me: “If China and the US can’t cooperate on health issues, they can’t cooperate on others.” His words underscore the dire state of bilateral…